Library / Peptides / Recovery & Healing / PEG-MGF
Theoretical · Grade C

PEG-MGF

PEG-MGF (PEGylated Mechano Growth Factor)
Evidence
Theoretical
Route
Intramuscular injection (site-specific)
Frequency
2-3x per week on training days
Category
Recovery & Healing
TL;DR
PEG-MGF is a PEGylated (polyethylene glycol-modified) form of mechano growth factor, a splice variant of IGF-1 (insulin-like growth factor 1) that is produced in response to mechanical stress on muscle tissue. PEGylation extends its half-life from minutes to hours.
Part 01 · How it works

Mechanism.

PEG-MGF is a PEGylated (polyethylene glycol-modified) form of mechano growth factor, a splice variant of IGF-1 (insulin-like growth factor 1) that is produced in response to mechanical stress on muscle tissue. PEGylation extends its half-life from minutes to hours. MGF activates muscle satellite cells and promotes muscle repair. PEG-MGF is used in bodybuilding and anti-aging contexts but has no approved medical use and very limited human research.

When you exercise hard enough to cause micro-tears in muscle, your body produces MGF as a repair signal to wake up dormant muscle stem cells. PEG-MGF is a lab-made version of that signal with a protective coating that keeps it active in your bloodstream much longer than the natural version.

Mechanism · technical
MGF (also known as IGF-1Ec in humans) is produced by mechanically stressed muscle tissue through alternative splicing of the IGF-1 gene. It activates quiescent muscle satellite (stem) cells, initiating their proliferation and differentiation into new myofibers for muscle repair and growth. PEGylation attaches polyethylene glycol chains to the peptide, protecting it from rapid enzymatic degradation and extending its circulating half-life, allowing systemic administration rather than requiring local injection.
Part 02 · Dosing & administration

How it's taken.

Community-reported · unregulated

Values below reflect commonly reported community protocols for PEG-MGF. These are anecdotal and unregulated — not clinically validated and not a recommendation. Provided for educational purposes only — this is not medical advice and not instructions for self-administration. Consult your healthcare provider before making any health decision.

Standard dose
200-400 mcg
Intramuscular injection (site-specific) · 2-3x per week on training days
Duration
4–6 week cycle
·
No human dosing literature exists — MGF/IGF-1Ec evidence is preclinical/animal only; the figure shown is a community convention, not evidence-based dosing.
·
PEGylation is claimed to extend half-life vs native MGF, but this and the local "site-specific growth" rationale are unproven in humans.
·
Research compound of unverified quality, not FDA-approved, and WADA-prohibited.
Need help with reconstitution?

Use the free peptide calculator for dilution, unit conversion, and injection volume.

Open calculator
Part 03 · Safety

Side effects, rare serious events, who shouldn't.

Reported side effects
Very limited human data. Reported side effects from anecdotal use include injection site pain and swelling, hypoglycemia, and joint pain. Theoretical concerns include promotion of cell proliferation in non-target tissues (potential cancer risk, as with other IGF-1 pathway activators). Long-term safety is completely unknown.
Absolute · do not use
×
Active malignancy or history of cancer (potent growth factor)
×
Pregnancy or breastfeeding
×
Children under 18
×
Known hypersensitivity to PEG-MGF or any component
×
Diabetic retinopathy
×
Active cardiac disease (effects on cardiac tissue remodeling)
Interactions
Insulin
IGF-1 related activity may potentiate hypoglycemia
Moderate
Growth hormone or other GH secretagogues
Additive growth factor signaling; increased risk of side effects including edema and joint pain
Moderate
Anticoagulants
Growth factors may affect wound healing and coagulation pathways
Minor
Labs to monitor
IGF-1
Baseline and monthly
MGF is a splice variant of IGF-1; monitor total IGF-1 levels
Fasting Glucose & Insulin
Baseline and monthly
IGF-1 family can affect glucose metabolism
CMP (Comprehensive Metabolic Panel)
Baseline and every 3 months
Liver and kidney function
CBC with Differential
Baseline and every 3 months
General safety monitoring
Part 04 · Research log

Every study we cite.

Each study with its published finding and a plain-language note on limitations or funding.

01
2005
0
Mechano growth factor expression in skeletal muscle after exercise
MGF is expressed in response to mechanical loading and is essential for muscle repair via satellite cell activation
Foundational mechanistic study; well-replicated
PMID 15389530 ↗
02
2010
0
PEGylated MGF promotes muscle regeneration
PEG-MGF enhanced muscle regeneration and reduced fibrosis in injured muscle in animal models
Preclinical; small study
Part 05 · Cost & access

Where you can get it.

Regulatory status
Not FDA-approved for any indication. Classified as a research chemical. Banned by WADA (World Anti-Doping Agency) as a prohibited substance under the growth factor category. Available through grey-market peptide suppliers.
The Peptide Column takes no affiliate commission from any source.
Part 06 · Your appointment

Questions to bring.

01
What is the actual human evidence for PEG-MGF versus natural recovery strategies?
02
How does PEG-MGF differ from other IGF-1 variants in terms of safety?
03
Should I be concerned about proliferative effects on non-muscle tissues?
04
What monitoring would be appropriate if using PEG-MGF?
References

Every citation, numbered.

Citation list. For our editorial read of each study — including bias flags and quality grades — see the Research log above.

  1. 01.
    Mechano growth factor expression in skeletal muscle after exercise · 2005 · PMID 15389530 ↗
  2. 02.
    PEGylated MGF promotes muscle regeneration · 2010